RT Journal Article
SR Electronic
T1 Biobanking in Latinos: current status, principles for conduct, and contribution of a new biobank, El Banco por Salud, designed to improve the health of Latino patients of Mexican ancestry with type 2 diabetes
JF BMJ Open Diabetes Research & Care
JO BMJ Open Diab Res Care
FD American Diabetes Association
SP e002709
DO 10.1136/bmjdrc-2021-002709
VO 10
IS 3
A1 Parra, Oscar D
A1 Kohler, Lindsay N
A1 Landes, Lori
A1 Soto, Alexis A
A1 Garcia, Diana
A1 Mullins, Jacqueline
A1 Molina, Patty
A1 Pereira, Eladio
A1 Spegman, Douglas J
A1 Soltani, Lisa
A1 Mandarino, Lawrence J
YR 2022
UL http://drc.bmj.com/content/10/3/e002709.abstract
AB Underserved Latino communities experience a greater burden of type 2 diabetes mellitus (T2DM) than the general population. Predictors of glycemic control are likely to include both biological/genetic and social determinants of health (SDOH). A variety of approaches have been used with cohorts of Latino patients to study aspects of this health disparity, and those are reviewed briefly here. Such projects range from cohorts that are studies for a primary purpose, for example, to discover genetic variation associated with T2DM or to examine a particular aspect of SDOH that might be involved. Other studies have been conducted more as infrastructure that is broadly based in order to provide a resource that can be used by many investigators to address a variety of questions. From our experience and those of others, we propose a set of principles to ensure that needs of the community are identified and taken into account during the conduct of these studies. As an example of the implementation of these principles, we also describe a new biobank El Banco por Salud (El Banco), which was designed to improve access to studies designed to improve glycemic control and health in Latinos in partnership with Federally Qualified Health Centers in Arizona.Data are available on reasonable request. The data captured for this biobank can be made available by the authors with approval by the CDDOM Biobank Executive Joint Governance Committee.